{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:53:13Z","timestamp":1760622793252},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,1,5]],"date-time":"2011-01-05T00:00:00Z","timestamp":1294185600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s10096-010-1119-4","type":"journal-article","created":{"date-parts":[[2011,1,4]],"date-time":"2011-01-04T16:41:26Z","timestamp":1294159286000},"page":"555-559","source":"Crossref","is-referenced-by-count":33,"title":["Evaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy alone"],"prefix":"10.1007","volume":"30","author":[{"given":"J. A.","family":"Silva Medeiros","sequence":"first","affiliation":[]},{"given":"T. M.","family":"F. O. Gon\u00e7alves","sequence":"additional","affiliation":[]},{"given":"L.","family":"Boyanova","sequence":"additional","affiliation":[]},{"given":"M. I.","family":"Correia Pereira","sequence":"additional","affiliation":[]},{"given":"J. N.","family":"Silva Paiva de Carvalho","sequence":"additional","affiliation":[]},{"given":"A. M.","family":"Sousa Pereira","sequence":"additional","affiliation":[]},{"given":"A. M.","family":"Silv\u00e9rio Cabrita","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,1,5]]},"reference":[{"key":"1119_CR1","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/gut.2003.022111","volume":"53","author":"F Megraud","year":"2004","unstructured":"Megraud F (2004) H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53:1374\u20131384. doi: 10.1136\/gut.2003.022111","journal-title":"Gut"},{"key":"1119_CR2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0924-8579(03)00153-5","volume":"22","author":"JM Hamilton-Miller","year":"2003","unstructured":"Hamilton-Miller JM (2003) The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrob Agents 22:360\u2013366. doi: 10.1016\/S0924-8579(03)00153-5","journal-title":"Int J Antimicrob Agents"},{"key":"1119_CR3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/AEM.70.1.518-526.2004","volume":"70","author":"D Sgouras","year":"2004","unstructured":"Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, Kalantzopoulos G, Tsakalidou E, Mentis A (2004) In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol 70:518\u2013526. doi: 10.1128\/AEM.70.1.518-526.2004","journal-title":"Appl Environ Microbiol"},{"key":"1119_CR4","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1046\/j.1440-1746.2003.03102.x","volume":"18","author":"A Ushiyama","year":"2003","unstructured":"Ushiyama A, Tanaka K, Aiba Y, Shiba T, Takagi A, Mine T, Koga Y (2003) Lactobacillus gasseri OLL2716 as a probiotic in clarithromycin-resistant Helicobacter pylori infection. J Gastroenterol Hepatol 18:986\u2013991. doi: 10.1046\/j.1440-1746.2003.03102.x","journal-title":"J Gastroenterol Hepatol"},{"key":"1119_CR5","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1046\/j.1365-2036.2000.00885.x","volume":"14","author":"F Canducci","year":"2000","unstructured":"Canducci F, Armuzzi A, Cremonini F, Cammarota G, Bartolozzi F, Pola P, Gasbarrini G, Gasbarrini A (2000) A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 14:1625\u20131629. doi: 10.1046\/j.1365-2036.2000.00885.x","journal-title":"Aliment Pharmacol Ther"},{"key":"1119_CR6","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S1590-8658(00)80343-6","volume":"32","author":"V Francesco De","year":"2000","unstructured":"De Francesco V, Stoppino V, Sgarro C, Faleo D (2000) Lactobacillus acidophilus administration added to omeprazole\/amoxycillin-based double therapy in Helicobacter pylori eradication. Dig Liver Dis 32:746\u2013747. doi: 10.1016\/S1590-8658(00)80343-6","journal-title":"Dig Liver Dis"},{"issue":"Suppl 3","key":"1119_CR7","first-page":"123","volume":"57","author":"W Ziemniak","year":"2006","unstructured":"Ziemniak W (2006) Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics. J Physiol Pharmacol 57(Suppl 3):123\u2013141","journal-title":"J Physiol Pharmacol"},{"issue":"Suppl 2","key":"1119_CR8","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S1590-8658(02)80172-4","volume":"34","author":"F Canducci","year":"2002","unstructured":"Canducci F, Cremonini F, Armuzzi A, Di Caro S, Gabrielli M, Santarelli L, Nista E, Lupascu A, De Martini D, Gasbarrini A (2002) Probiotics and Helicobacter pylori eradication. Dig Liver Dis 34(Suppl 2):S81\u2013S83. doi: 10.1016\/S1590-8658(02)80172-4","journal-title":"Dig Liver Dis"},{"key":"1119_CR9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jac\/47.5.709","volume":"47","author":"I Sakamoto","year":"2001","unstructured":"Sakamoto I, Igarashi M, Kimura K, Takagi A, Miwa T, Koga Y (2001) Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother 47:709\u2013710. doi: 10.1093\/jac\/47.5.709","journal-title":"J Antimicrob Chemother"},{"key":"1119_CR10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1572-0241.2003.07517.x","volume":"98","author":"ME Leerdam Van","year":"2003","unstructured":"Van Leerdam ME, van der Ende A, ten Kate FJ, Rauws EA, Tytgat GN (2003) Lack of accuracy of the noninvasive Helicobacter pylori stool antigen test in patients with gastroduodenal ulcer bleeding. Am J Gastroenterol 98:798\u2013801","journal-title":"Am J Gastroenterol"},{"key":"1119_CR11","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1128\/JCM.35.11.2931-2936.1997","volume":"35","author":"L Monteiro","year":"1997","unstructured":"Monteiro L, Cabrita J, M\u00e9graud F (1997) Evaluation of performances of three DNA enzyme immunoassays for detection of Helicobacter pylori PCR products from biopsy specimens. J Clin Microbiol 35:2931\u20132936","journal-title":"J Clin Microbiol"},{"key":"1119_CR12","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/AAC.43.11.2747","volume":"43","author":"F Megraud","year":"1999","unstructured":"Megraud F, Lehn N, Lind T, Bayerd\u00f6rffer E, O'Morain C, Spiller R, Unge P, van Zanten SV, Wrangstadh M, Burman CF (1999) Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother 43:2747\u20132752","journal-title":"Antimicrob Agents Chemother"},{"key":"1119_CR13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/fampra\/cmh219","volume":"21","author":"MJ Huibers","year":"2004","unstructured":"Huibers MJ, Bleijenberg G, Beurskens AJ, Kant IJ, Knottnerus JA, van der Windt DA, Bazelmans E, van Schayck CP (2004) An alternative trial design to overcome validity and recruitment problems in primary care research. Fam Pract 21:213\u2013218. doi: 10.1093\/fampra\/cmh219","journal-title":"Fam Pract"},{"issue":"Suppl 2","key":"1119_CR14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1523-5378.2007.00565.x","volume":"12","author":"F Franceschi","year":"2007","unstructured":"Franceschi F, Cazzato A, Nista EC, Scarpellini E, Roccarina D, Gigante G, Gasbarrini G, Gasbarrini A (2007) Role of probiotics in patients with Helicobacter pylori infection. Helicobacter 12(Suppl 2):59\u201363. doi: 10.1111\/j.1523-5378.2007.00565.x","journal-title":"Helicobacter"},{"key":"1119_CR15","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1128\/JCM.27.10.2328-2330.1989","volume":"27","author":"SJ Bhatia","year":"1989","unstructured":"Bhatia SJ, Kochar N, Abraham P, Nair NG, Mehta AP (1989) Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol 27:2328\u20132330","journal-title":"J Clin Microbiol"},{"issue":"3 Suppl 2","key":"1119_CR16","doi-asserted-by":"crossref","first-page":"812S","DOI":"10.1093\/jn\/137.3.812S","volume":"137","author":"D Lesbros-Pantoflickova","year":"2007","unstructured":"Lesbros-Pantoflickova D, Corth\u00e9sy-Theulaz I, Blum AL (2007) Helicobacter pylori and probiotics. J Nutr 137(3 Suppl 2):812S\u2013818S","journal-title":"J Nutr"},{"key":"1119_CR17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4315\/0362-028X-66.1.3","volume":"66","author":"TS Kim","year":"2003","unstructured":"Kim TS, Hur JW, Yu MA, Cheigh CI, Kim KN, Hwang JK, Pyun YR (2003) Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria. J Food Prot 66:3\u201312","journal-title":"J Food Prot"},{"key":"1119_CR18","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3748\/wjg.14.1477","volume":"14","author":"Y Niv","year":"2008","unstructured":"Niv Y (2008) H pylori recurrence after successful eradication. World J Gastroenterol 14:1477\u20131478. doi: 10.3748\/wjg.14.1477","journal-title":"World J Gastroenterol"},{"key":"1119_CR19","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1111\/j.1572-0241.2002.07063.x","volume":"97","author":"F Cremonini","year":"2002","unstructured":"Cremonini F, Di Caro S, Covino M, Armuzzi A, Gabrielli M, Santarelli L, Nista E, Cammarota G, Gasbarrini G, Gasbarrini A (2002) Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 97:2744\u20132749. doi: 10.1111\/j.1572-0241.2002.07063.x","journal-title":"Am J Gastroenterol"},{"key":"1119_CR20","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1046\/j.1365-2036.2002.01335.x","volume":"16","author":"B Sheu","year":"2002","unstructured":"Sheu B, Wu J, Lo C, Wu H, Chen J, Lin Y, Lin M (2002) Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 16:1669\u20131675. doi: 10.1046\/j.1365-2036.2002.01335.x","journal-title":"Aliment Pharmacol Ther"},{"key":"1119_CR21","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/ajcn\/83.4.864","volume":"83","author":"BS Sheu","year":"2006","unstructured":"Sheu BS, Cheng HC, Kao AW, Wang ST, Yang YJ, Yang HB, Wu JJ (2006) Pretreatment with Lactobacillus- and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy. Am J Clin Nutr 83:864\u2013869","journal-title":"Am J Clin Nutr"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1119-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-010-1119-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1119-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T21:29:43Z","timestamp":1637098183000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-010-1119-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,5]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["1119"],"URL":"https:\/\/doi.org\/10.1007\/s10096-010-1119-4","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,5]]}}}